Skip to main content
OpenTrials

Clinical trial condition

Non-alcoholic Fatty Liver Disease

Explore clinical trials studying Non-alcoholic Fatty Liver Disease. Study availability and eligibility vary by location and protocol.

1,138 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Non-alcoholic Fatty Liver Disease trial results

Completed

Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

NCT04971785

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Digestive Health Specialists Dothan, Alabama, United States
  • North Alabama Health Research, LLC Madison, Alabama, United States
  • The Institution For Liver Health dba Arizona Liver Health Chandler, Arizona, United States
View all 242 locations
View Trial Details
Completed

Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

NCT05016882

Conditions
Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations
  • North AL Health Res, LLC Huntsville, Alabama, United States
  • The Institute for Liver Health Chandler, Arizona, United States
  • Inst-Liver Hlth dba AZ Liver H Peoria, Arizona, United States
  • Del Sol Research Management, LLC Tucson, Arizona, United States
View all 255 locations
View Trial Details
Completed

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

NCT05809934

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +6 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Peoria, Arizona, United States
  • Research Site Surprise, Arizona, United States
  • Research Site Tucson, Arizona, United States
View all 164 locations
View Trial Details
Completed

A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

NCT06052566

Conditions
Digestive System Diseases, Fatty Liver, Hepatic Impairment, +3 more
Locations
  • Clinical Pharmacology of Miami ( Site 0005) Miami, Florida, United States
  • Advanced Pharma CR, LLC ( Site 0001) Miami, Florida, United States
  • Genesis Clinical Research, LLC ( Site 0006) Tampa, Florida, United States
  • American Research Corporation ( Site 0002) San Antonio, Texas, United States
View Trial Details

Related conditions